These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1336341)

  • 21. Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.
    Pai SB; Pai RB; Xie MY; Beker T; Shi J; Tharnish PM; Chu CK; Schinazi RF
    Antivir Chem Chemother; 2005; 16(3):183-92. PubMed ID: 16004081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular pharmacology of the anti-hepatitis B virus agent beta-L-2',3'-didehydro-2',3'-dideoxy-N4-hydroxycytidine: relevance for activation in HepG2 cells.
    Matthes E; Bünger H
    Antimicrob Agents Chemother; 2010 Jan; 54(1):341-5. PubMed ID: 19917760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hepatitis B virus in tissue culture by alpha interferon.
    Davis MG; Jansen RW
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2921-4. PubMed ID: 7695285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.
    Schinazi RF; Boudinot FD; Ibrahim SS; Manning C; McClure HM; Liotta DC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2432-8. PubMed ID: 1336946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
    Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
    J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of hepatitis B virus production by modified 2',3'-dideoxy-thymidine and 2',3'-dideoxy-5-methylcytidine derivatives. In vitro and in vivo studies.
    Matthes E; von Janta-Lipinski M; Will H; Schröder HC; Merz H; Steffen R; Müller WE
    Biochem Pharmacol; 1992 Apr; 43(7):1571-7. PubMed ID: 1314607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
    Nair S; Zlotnick A
    J Virol; 2018 May; 92(10):. PubMed ID: 29491156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.
    Nair V; St Clair MH; Reardon JE; Krasny HC; Hazen RJ; Paff MT; Boone LR; Tisdale M; Najera I; Dornsife RE
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1993-9. PubMed ID: 8540705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.
    Cui L; Schinazi RF; Gosselin G; Imbach JL; Chu CK; Rando RF; Revankar GR; Sommadossi JP
    Biochem Pharmacol; 1996 Nov; 52(10):1577-84. PubMed ID: 8937473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents.
    Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J
    Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative pharmacokinetics of Racivir, (+/-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine in rats, rabbits, dogs, monkeys and HIV-infected humans.
    Hurwitz SJ; Otto MJ; Schinazi RF
    Antivir Chem Chemother; 2005; 16(2):117-27. PubMed ID: 15889534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
    Delaney WE; Miller TG; Isom HC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
    Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
    Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
    Siddiqui MA; Driscoll JS; Marquez VE; Roth JS; Shirasaka T; Mitsuya H; Barchi JJ; Kelley JA
    J Med Chem; 1992 Jun; 35(12):2195-201. PubMed ID: 1351945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs.
    Faraj A; Agrofoglio LA; Wakefield JK; McPherson S; Morrow CD; Gosselin G; Mathe C; Imbach JL; Schinazi RF; Sommadossi JP
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2300-5. PubMed ID: 7530932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
    Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
    Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.
    Matthes E; Funk A; Krahn I; Gaertner K; von Janta-Lipinski M; Lin L; Will H; Sirma H
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2523-30. PubMed ID: 17404006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
    Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
    Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.